GSK
GSK | NYSE
$49.13
-$0.38 (-0.77%)
At close: Nov 2, 2026, 3:59 PM ET
$49.13
-$0.38 (-0.77%)
Pre-market:
Nov 2, 2026, 9:16 AM ET
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 4.43B | 5.62B | 6.83B | 6.76B | 6.63B | 3.98B | 3.64B | 3.2B | 3.13B | 4.6B | 5.04B | 5.34B | 6.67B | 6.03B | 4.63B | 4.77B | 3.59B | 3.9B | 5.25B | 4.74B | 5.06B | 5.28B | 6.02B |
Depreciation & Amortization | 2.21B | 2.21B | 3.14B | 3.5B | 3.13B | 3.35B | 2.83B | 2.55B | 2.76B | 2.39B | 2.2B | 2.29B | 1.68B | 2.05B | 2.52B | 2.3B | 2.6B | 2.55B | 2.18B | 2.12B | 4.5B | 4.23B | 2.52B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -132.67M | -777.4M | -1.8B | -1.5B | 873.2M | 1.2B | 1.61B | 2.01B | 69.15M | 973.15M | -401.85M | -847.52M | -1.75B | -2.49B | -27.8M | 333.2M | 1.53B | 1.57B | 709.22M | 649.22M | 1.86B | 184.18M | 2.68B |
Other Non-Cash Items | 1.99B | 1.69B | 127.63M | -455.37M | -2.04B | -805M | -1.34B | -967.34M | 3.19B | 1.24B | 2.56B | 1.47B | -319.58M | -70.65M | -1.28B | 931.35M | 3.78B | 5.53B | 5.12B | 3.54B | -714.46M | -1.64B | -1.76B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.07B | -1.07B | -1.07B | -1.07B | -957.94M | -957.94M | -957.94M | -957.94M | -1.16B | -1.16B | -1.16B | -1.16B | -888.03M | -888.03M | -888.03M |
Change in Working Capital | -132.67M | -777.4M | -1.8B | -1.5B | 873.2M | 1.2B | 1.61B | 2.01B | 69.15M | 973.15M | -401.85M | -847.52M | -1.75B | -2.49B | -27.8M | 333.2M | 1.53B | 1.57B | 709.22M | 649.22M | 1.86B | 184.18M | 2.68B |
Operating Cash Flow | 8.5B | 8.74B | 8.3B | 8.3B | 8.6B | 7.72B | 6.74B | 6.79B | 8.08B | 8.13B | 8.33B | 7.19B | 5.32B | 4.56B | 4.89B | 7.38B | 10.33B | 12.38B | 12.1B | 9.89B | 9.81B | 7.17B | 8.58B |
Capital Expenditures | -1.7B | -1.76B | -2.06B | -2.07B | -2.64B | -3.06B | -2.87B | -2.73B | -2.19B | -1.84B | -1.93B | -2.15B | -2.07B | -1.9B | -1.79B | -1.83B | -1.83B | -1.81B | -1.6B | -1.38B | -1.55B | -1.89B | -2.08B |
Cash Acquisitions | -11.69B | -5.72B | -5.09B | -4.75B | -2.11B | -975M | 230M | 141.81M | 258.64M | 202.64M | -1.51B | -646.18M | -522.58M | -4.26B | -3.79B | -3.81B | -3.97B | -171M | -83.83M | -98.83M | -35.25M | 36.72M | 2.72B |
Purchase of Investments | -95.97M | -69.01M | -49.93M | -49.93M | -10.82M | n/a | n/a | -22.82M | -148.69M | -181.69M | -184.69M | -217.87M | -115.67M | -159.49M | -170.49M | -114.49M | -110.36M | -66.6M | -81.85M | -63.85M | -77.21M | -233.16M | -385.91M |
Sales Maturities Of Investments | 257.45M | 385.84M | 224.02M | 224.02M | 174.4M | n/a | n/a | 1.37B | 2.62B | 2.69B | 3.49B | 2.13B | 1.03B | 1.1B | 302.73M | 291.73M | 145.92M | 33.32M | 597.11M | 615.11M | 864.12M | 1.1B | 3.36B |
Other Investing Acitivies | 1.49B | 1.62B | 996.88M | 965.88M | -878.49M | -1.33B | -1.1B | -954.57M | -386.7M | 62.3M | -523.7M | -336.13M | -215.22M | -957.31M | -307.31M | -3.86B | -3.79B | -3.06B | -3.07B | 462.55M | 993.85M | 562.61M | -1.68B |
Investing Cash Flow | -12.44B | -6.86B | -6.6B | -6.28B | -5.04B | -3.62B | -2.22B | -1.33B | 76.32M | 316.32M | -1.42B | -1.57B | -2.25B | -6.76B | -6.35B | -9.53B | -9.62B | -6.26B | -5.99B | -2.44B | -2.01B | -924.03M | 2.18B |
Debt Repayment | 6.46B | 998.88M | 141.62M | 877.62M | 586.47M | 117M | 1.08B | -1.25B | -4.93B | -5.43B | -3.85B | -3.03B | 1.31B | 1.03B | -2.82B | -3.28B | -6.13B | -5.13B | -2.8B | -2.75B | -1.55B | -4.07B | -4.13B |
Common Stock Repurchased | -635.66M | -1.08B | -1.34B | -1.26B | -1.26B | -808M | -247M | n/a | n/a | n/a | n/a | -2M | -2M | 1.9M | 5.9M | 899.07K | 899.07K | -3M | -7M | n/a | n/a | n/a | n/a |
Dividend Paid | -2.68B | -2.91B | -2.83B | -2.8B | -2.79B | -2.49B | -2.49B | -2.6B | -2.66B | -2.61B | -2.52B | -2.35B | -2.38B | -2.61B | -3.21B | -3.6B | -4.16B | -4.68B | -5.14B | -5.13B | -5.17B | -4.79B | -4.32B |
Other Financial Acitivies | 741.18M | 448.71M | 1.02B | 754.74M | -620.12M | -426M | -1.16B | -1.1B | -578.57M | -648.57M | -705.57M | -735.49M | -2.3B | -1.79B | -1.86B | 7.3B | 8.7B | 8.09B | 8.31B | -1.11B | -1.48B | -1.74B | -2.38B |
Financial Cash Flow | 3.9B | -2.53B | -3B | -2.41B | -4.06B | -3.6B | -2.81B | -4.92B | -8.14B | -8.66B | -7.05B | -6.11B | -3.36B | -3.34B | -7.86B | 429.38M | -1.59B | -1.71B | 376.57M | -8.97B | -8.17B | -10.58B | -10.81B |
Net Cash Flow | -430.98M | -760.69M | -1.37B | -475.76M | -198.65M | 445M | 1.66B | 596.65M | 86.78M | -80.22M | -54.22M | -539.87M | 48.02M | -3.76B | -7.4B | 235.98M | 916.03M | 4.56B | 6.16B | -1.9B | 28.41M | -3.81B | 863.79M |
Free Cash Flow | 6.79B | 6.98B | 6.24B | 6.24B | 5.95B | 4.67B | 3.87B | 4.05B | 5.89B | 6.29B | 6.39B | 5.04B | 3.25B | 2.66B | 3.1B | 5.54B | 8.5B | 10.57B | 10.5B | 8.51B | 8.26B | 5.28B | 6.5B |
Adj. Free Cash Flow | 6.79B | 6.98B | 6.24B | 6.24B | 5.95B | 4.67B | 3.87B | 4.05B | 5.89B | 6.29B | 6.39B | 5.04B | 3.25B | 2.66B | 3.1B | 5.54B | 8.5B | 10.57B | 10.5B | 8.51B | 8.26B | 5.28B | 6.5B |
Maintenance CapEx | -1.39B | -1.22B | -1.59B | -1.53B | -2.28B | -2.92B | -2.47B | -2.23B | -1.41B | -926.94M | -1.21B | -1.61B | -1.82B | -1.47B | -1.04B | -1.08B | -724.19M | -1.03B | -1.25B | -1.03B | -1.55B | -1.89B | -2.08B |
Growth CapEx | -314.99M | -540.14M | -478.93M | -543.32M | -360.4M | -135.24M | -395.66M | -508.29M | -775.12M | -913.78M | -719.02M | -542M | -247.23M | -436.72M | -754.15M | -754.15M | -1.1B | -775.97M | -349.97M | -349.97M | n/a | n/a | n/a |
Owner Earnings | 7.11B | 7.52B | 6.72B | 6.78B | 6.31B | 4.8B | 4.27B | 4.56B | 6.67B | 7.21B | 7.11B | 5.58B | 3.5B | 3.1B | 3.85B | 6.3B | 9.61B | 11.35B | 10.85B | 8.86B | 8.26B | 5.28B | 6.5B |
Add to Watchlist
Select watchlists to add or remove GSK